We are live on
!
Find out more
GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $20.7K | -$44.2K | -49,686 | -64% |
|
2
Morgan Stanley
New York
| $15K | +$1.25K | +1,400 | +8% |
|
3
BNP Paribas Financial Markets
Paris,
France
| $11.7K | +$2.22K | +2,500 | +20% |
|
|
TSS
4
Two Sigma Securities
New York
| $11.2K | +$12.9K | +14,457 | New |
|
5
UBS Group
Zurich,
Switzerland
| $6.87K | +$7.88K | +8,866 | New |
|
6
RhumbLine Advisers
Boston,
Massachusetts
| $2.79K | – | – | – |
|
7
Citadel Advisors
Miami,
Florida
| $510 | +$606 | +682 | New |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $310 | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $13 | +$16 | +18 | New |
|
|
ATS
10
Ashton Thomas Securities
Rochester,
New York
| $4 | +$4 | +5 | New |
|
|
AC
11
Armistice Capital
New York
| – | -$210K | -140,000 | Closed |
|